Goldenwell Biotech, Inc. financial data

Symbol
GWLL on OTC
Location
581 Boston Mills Road, Suite 300, Hudson, OH
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 22, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Quick Ratio 294 % -27.2%
Debt-to-equity 229 % +856%
Return On Equity -221 % +58%
Return On Assets -67.3 % +84.2%
Operating Margin -14.6K % -572%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99M shares 0%
Common Stock, Shares, Outstanding 99M shares 0%
Entity Public Float 12.7M USD 0%
Common Stock, Value, Issued 9.9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 96.4M shares +5.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 939 USD -97.9%
Cost of Revenue 531 USD -97.5%
General and Administrative Expense 138K USD -86.4%
Operating Income (Loss) -137K USD +86.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -137K USD +86.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.7K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Inventory, Net 175K USD -0.3%
Operating Lease, Right-of-Use Asset 0 USD
Assets 200K USD +4.19%
Accounts Payable, Current 0 USD
Liabilities, Current 29.1K USD -76.9%
Liabilities 197K USD +282%
Retained Earnings (Accumulated Deficit) -1.31M USD -11.7%
Stockholders' Equity Attributable to Parent 3.83K USD -97.3%
Liabilities and Equity 200K USD +4.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -137K USD +85.8%
Net Cash Provided by (Used in) Financing Activities 51.4K USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 99M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.7K USD +50.1%
Deferred Tax Assets, Valuation Allowance 275K USD +11.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability, Current 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 25.4K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.6K USD
Deferred Tax Assets, Operating Loss Carryforwards 275K USD +11.7%
Additional Paid in Capital 1.3M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD